Prof. Dr. Dario Neri, Philogen’s CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusion Proteins for Cancer Therapy: Late-Stage Clinical Results”

Dr. Samuele Cazzamalli, Philogen Head of Small Molecule Therapeutics is giving a presentation entitled “From DNA-Encoded Chemistry to anti-cancer Radio Ligand Therapeutics and Small Molecule-Drug Conjugates”.

Follow the link for more details